The DOI matches its Crossref record; 350 of the 352 references it cites were found in a registry or an index.
Primary Hepatocytes: Current Understanding of the Regulation of Metabolic Enzymes and Transporter Proteins, and Pharmaceutical Practice for the Use of Hepatocytes in Metabolism, Enzyme Induction, Transporter, Clearance, and Hepatotoxicity Studies
Abstract
This review brings you up-to-date with the hepatocyte research on: 1) in vitro-in vivo correlations of metabolism and clearance; 2) CYP enzyme induction, regulation, and cross-talk using human hepatocytes and hepatocyte-like cell lines; 3) the function and regulation of hepatic transporters and models used to elucidate their role in drug clearance; 4) mechanisms and examples of idiosyncratic and intrinsic hepatotoxicity; and 5) alternative cell systems to primary human hepatocytes. We also report pharmaceutical perspectives of these topics and compare methods and interpretations for the drug development process.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
1 retracted
RETRACTED ARTICLE: Pluripotency of mesenchymal stem cells derived from adult marrow
Jiang, Y., Jahagirdar, B. N., Reinhardt, R. L., Schwartz, R. E., Keene, C. D., Ortiz-Gonzalez, X. R., Reyes, M., Lenvik, T., Lund, T., Blackstad, M., et al. (2002) · Nature · doi:10.1038/nature00870 · Cited by 5,518
RetractedPhysiological Parameters in Laboratory Animals and Humans
Davies, B., & Morris, T. (1993) · Pharmaceutical Research · doi:10.1023/a:1018943613122 · Cited by 2,926
Shimada, T., Yamazaki, H., Mimura, M., Inui, Y., & Guengerich, F. P. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22379-5 · Cited by 2,785
Ostapowicz, G., Fontana, R. J., Schiødt, F. V., Larson, A., Davern, T. J., Han, S. H. B., McCashland, T. M., Shakil, A. O., Hay, J. E., Hynan, L., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-12-200212170-00007 · Cited by 2,227
NELSON, D. R., KAMATAKI, T., WAXMAN, D. J., GUENGERICH, F. P., ESTABROOK, R. W., FEYEREISEN, R., GONZALEZ, F. J., COON, M. J., GUNSALUS, I. C., GOTOH, O., et al. (1993) · DNA and Cell Biology · doi:10.1089/dna.1993.12.1 · Cited by 1,655
Lee, W. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021844 · Cited by 1,594
Lehmann, J. M., McKee, D. D., Watson, M. A., Willson, T. M., Moore, J. T., & Kliewer, S. A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3703 · Cited by 1,576
Wu, C.-Y., & Benet, L. Z. (2005) · Pharmaceutical Research · doi:10.1007/s11095-004-9004-4 · Cited by 1,401
Infection of a human hepatoma cell line by hepatitis B virus
Gripon, P., Rumin, S., Urban, S., Le Seyec, J., Glaise, D., Cannie, I., Guyomard, C., Lucas, J., Trepo, C., & Guguen-Guillouzo, C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.232137699 · Cited by 1,282
Burke, M. D., Thompson, S., Elcombe, C. R., Halpert, J., Haaparanta, T., & Mayer, R. T. (1985) · Biochemical Pharmacology · doi:10.1016/0006-2952(85)90355-7 · Cited by 1,275
Research works printed but not linked: 48
- Allen S. W., 2001, Drug Metab. Dispos., 29, 1074
- Andersson T. B., 2001, Drug Metab. Dispos., 29, 712
- Arand M., 2003, EXCLI J., 22, 22
- 10.1177/0091270003252519 · doi:10.1177/0091270003252519 · Paper page
- Bort R., 1996, Drug Metab. Dispos., 24, 834
- Bort R., 1996, Drug Metab. Dispos., 24, 969
- Brown H. S., 2006, Drug metab. Dispos., 200, 6
- Chauret N., 1998, Drug Metab. Dispos., 26, 1
- Code E. L., 1997, Drug Metab. Dispos., 25, 985
- Cui Y., 2001, Mol. Pharmacol., 60, 934, 10.1124/mol.60.5.934 · doi:10.1124/mol.60.5.934 · Paper page
- Curi-Pedrosa R., 1994, J. Pharmacol. Exp. Ther., 269, 384
- Donato M. T., 1995, Drug Metab. Disp., 23, 553
- Drew R., 1985, Agents Actions Suppl., 17, 127
- Drocourt L., 2001, Drug Metab. Dispos., 29, 1325
- Easterbrook J., 2001, Drug Metab. Dispos., 29, 141
- Elferink M. G., 2004, Physiol., 287, G1008
- Eneroth A., 2006, Drug Metab. Rev., 38, 61
- Gerbal-Chaloin S., 2001, Drug Metab. Dispos., 29, 242
- Goodwin B., 1999, Mol. Pharmacol., 56, 1329, 10.1124/mol.56.6.1329 · doi:10.1124/mol.56.6.1329 · Paper page
- Grillo M. P., 2001, Drug Metab. Dispos., 29, 1210
- Guengerich F. P, 1990, Basic Life Sci., 53, 381
- Hallifax D., 2006, Drug Metab. Dispos.
- 10.1517/17425255.1.1.61 · DOI
- Hewitt N. J., 2001, Drug Metab. Dispos., 29, 1042
- Hewitt N. J., Chem. Biol. Interact.
- Hickman D., 1998, Drug Metab. Dispos., 26, 207
- Hopwood J., 2004, Toxicology, 202, 103
- Klingmüller U., 2006, Systems Biology
- Koganti A., 2005, Drug Metab. Rev., 37, 212
- Kolars J. C., 1991, Hepatology, 13, 197
- Lieu Y. K., 1997, Am. J. Physiol., 272, E359
- 10.1016/j.cbi.2004.09.010 · DOI
- Liu X., 1999, Am. J. Physiol., 277, G12
- Lu A. Y. H, 1998, Drug Metab. Dispos., 26, 1217
- Nomeir A. A., 2001, Drug Metab. Dispos., 29, 748
- Nussler A., 2006, J. Hepatol., 200, 6
- Olinga P., 1998, Drug Metab. Dispos., 26, 5
- Parkinson A, 2001, Casserett and Doull's Toxicology. The Basic Science of Poisons 6th, 133
- Pascussi J. M., 2000, Mol. Pharmacol., 58, 361, 10.1124/mol.58.2.361 · doi:10.1124/mol.58.2.361 · Paper page
- Pascussi J. M., 2000, Mol. Pharmacol., 58, 1441, 10.1124/mol.58.6.1441 · doi:10.1124/mol.58.6.1441 · Paper page
- Ruegg C. E., 1997, In Vitro Technol., 10, 217
- Ruhnke M., 2005, Gastroenterology
- Shimada T., 1994, J. Pharmacol. Exp. Ther., 270, 414
- Stogniew M., 1982, Drug Metab. Dispos., 10, 609
- van Breemen R. B., 1985, Drug Metab. Dispos., 13, 318
- Wahlstrom A., 1989, Drug Metab. Dispos., 17, 218
- Wenz A., 1981, J. Biol. Chem., 256, 9809, 10.1016/S0021-9258(19)68697-7 · DOI
- Zimmerman H. J, 1994, Nonsteroidal Anti-Inflammatory Drugs: Mechanisms and Clinical Uses 2nd
Cited by
The Many Roles for Fluorine in Medicinal Chemistry
Hagmann, W. K. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800219f · Cited by 3,578
Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1078-5 · Cited by 1,280
Self-citationMicroscale culture of human liver cells for drug development
Khetani, S. R., & Bhatia, S. N. (2008) · Nature Biotechnology · doi:10.1038/nbt1361 · Cited by 1,219
Deterministically patterned biomimetic human iPSC-derived hepatic model via rapid 3D bioprinting
Ma, X., Qu, X., Zhu, W., Li, Y.-S., Yuan, S., Zhang, H., Liu, J., Wang, P., Lai, C. S. E., Zanella, F., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1524510113 · Cited by 872
Bell, C. C., Hendriks, D. F. G., Moro, S. M. L., Ellis, E., Walsh, J., Renblom, A., Fredriksson Puigvert, L., Dankers, A. C. A., Jacobs, F., Snoeys, J., et al. (2016) · Scientific Reports · doi:10.1038/srep25187 · Cited by 739
Metadata
- Authors
- Hewitt, N. J., Gómez Lechón, M. J., Houston, J. B., Hallifax, D., Brown, H. S., Maurel, P., Kenna, J. G., Gustavsson, L., Lohmann, C., Skonberg, C., Guillouzo, A., Tuschl, G., Li, A. P., LeCluyse, E., Groothuis, G. M. M., & Hengstler, J. G.
- Affiliations
- University of Manchester (GB)
- Inserm (FR)
- AstraZeneca (Sweden) (SE)
- Merck KGaA, Darmstadt (Germany) (DE)
- University of Groningen (NL)
- Leipzig University (DE)
- ORCID
- Venue
- Drug Metabolism Reviews
- Publisher
- Informa UK Limited
- Published
- 2007-01
- Volume
- 39
- Issue
- 1
- Pages
- 159-234
- ISSN
- 0360-2532 (ISSN-L)
- 1097-9883
- OpenAlex
- W2171534546
- Cited by
- 735
- References
- 352
- Citations by year
- 2026: 11 · 2025: 14 · 2024: 18 · 2023: 17 · 2022: 15 · 2021: 32 · 2020: 33 · 2019: 28 · 2018: 38 · 2017: 31 · 2016: 44 · 2015: 51 · 2014: 55 · 2013: 53 · 2012: 71
- FWCI
- 6.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Drug Metabolism Reviews (publishedVersion)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- primary human hepatocytes, drug metabolism, drug transporters, drug clearance, in vitro-in vivo correlation, idiosyncratic hepatotoxicity, drug development
- MeSH terms
- Animals, Carrier Proteins, Cytochrome P-450 Enzyme System, Pharmaceutical Preparations, Humans, Liver Diseases, Metabolic Clearance Rate, Models, Biological, Xenobiotics, Hepatocytes, Chemical and Drug Induced Liver Injury, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Primary Hepatocytes: Current Understanding of the Regulation of Metabolic Enzymes and Transporter Proteins, and Pharmaceutical Practice for the Use of Hepatocytes in Metabolism, Enzyme Induction, Transporter, Clearance, and Hepatotoxicity Studies. https://app.cochat.ai/papers/10.1080/03602530601093489
- The paper
- Hewitt, N. J., Gómez Lechón, M. J., Houston, J. B., Hallifax, D., Brown, H. S., Maurel, P., Kenna, J. G., Gustavsson, L., Lohmann, C., Skonberg, C., Guillouzo, A., Tuschl, G., Li, A. P., LeCluyse, E., Groothuis, G. M. M., & Hengstler, J. G. (2007). Primary Hepatocytes: Current Understanding of the Regulation of Metabolic Enzymes and Transporter Proteins, and Pharmaceutical Practice for the Use of Hepatocytes in Metabolism, Enzyme Induction, Transporter, Clearance, and Hepatotoxicity Studies. Drug Metabolism Reviews. https://doi.org/10.1080/03602530601093489
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.